Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II, Double-Blind, Placebo-Controlled, Randomized Clinical Trial Assessing Toxicity and Efficacy of MF101 for Hot Flashes and Menopausal Symptoms

NCT00119665 is registered in ClinicalTrials.gov with Bionovo as lead sponsor.

NCT NCT00119665
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00119665 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II, Double-Blind, Placebo-Controlled, Randomized Clinical Trial Assessing Toxicity and Efficacy of MF101 for Hot Flashes and Menopausal Symptoms
Lead sponsor
Bionovo
Phase
Phase 2
Overall status
Completed
Start date
February 28, 2006
Completion date
February 28, 2007
Enrollment
180
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

hot flashes